Dosages needs to be individualized in accordance with the suggested target of therapy and also the client’s response. Rhabdomyolysis with renal dysfunction secondary to myoglobinuria have been reported with other HMG-CoA reductase inhibitors. This hasn't been claimed with cerivastatin s